Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Sean Garrity (NPI 1629496344)

Field	Value
Entity Type	Individual
Organization	Sean Garrity
Address	6561 E Carondelet Dr
City	Tucson
State	AZ
ZIP	85710
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 31, 2014

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

The provider is effectively single‑payer in scope: total Medicare revenue is $3.4M and there is no Medicaid billing on file. This means the practice’s reimbursement profile and financial exposure are concentrated in Medicare policy, pricing, and benefit changes rather than being balanced across payers. Analysts should treat this entity as Medicare‑dependent for population- and revenue‑level comparisons.

Revenue concentration is very high: the precomputed top‑3 Medicare codes account for 80.6% of this provider’s total Medicare revenue, led by J0178 at $2.3M (66.8%), followed by J2778 at $256.1K (7.4%) and 67028 at $220.7K (6.4%). This extreme concentration around anti‑VEGF drug administration and the intravitreal injection procedure means a small set of services drives the majority of payments. Monitoring utilization or reimbursement changes for these specific codes will capture the bulk of revenue risk or opportunity.

The code mix indicates a retina‑focused ophthalmology operation: J0178 (aflibercept) is the dominant revenue driver and is accompanied by J2778 (ranibizumab) and 67028 (intravitreal injection) as major billings. High volumes for adjunct diagnostic codes such as 92134 (retinal imaging) and procedures like 92235 (fluorescein angiography) are consistent with longitudinal management of retinal vascular disease and AMD. Together these codes point to an office‑based, procedure‑intensive practice model centered on anti‑VEGF therapy and retinal imaging follow‑up.

On competitive standing for key Medicare services, this provider is a high‑volume national participant: J0178 ranks #129 of 3204 providers nationally (96th percentile; notably above typical national volume) and 67028 ranks #253 of 4255 providers (94th percentile; notably above typical national volume). Imaging and E/M volumes are also elevated: 92134 ranks #233 of 26868 (99th percentile; extreme outlier) and 99214 ranks #828 of 479517 (100th percentile; extreme outlier). These rank positions indicate the provider is a major, high‑throughput operator for both drug administration and related diagnostic/office services relative to national peers.

Several codes are flagged as statistical outliers or notably above typical volumes, underscoring a concentrated high‑intensity practice pattern. In addition to J0178 and 67028 being described as notably above typical, 99214 and 92134 are labeled as extreme outliers and 99204 is also an extreme outlier (rank #1410 of 227068, 99th percentile). By contrast, J2778 (rank #309 of 1208, 74th percentile) and J2777 (rank #1521 of 2039, 25th percentile) are described as typical or unremarkable, highlighting that not all anti‑VEGF or related codes are uniformly elevated.

Operationally, the heavy reliance on a single high‑cost drug code is notable: J0178 carries a $694 avg paid/claim and represents $2.3M of revenue (66.8% of Medicare revenue). That concentration concentrates both reimbursement and drug‑acquisition risk around aflibercept volumes and pricing, meaning changes to drug payment policy or supply dynamics could disproportionately affect this provider’s revenue. For payer or network analysts, this makes detailed review of drug utilization patterns and buy‑and‑bill arrangements especially relevant.

Practice tenure appears stable: the NPI was enumerated 2014-03-31 (~12 years ago), indicating an established billing history. Combined with consistently high-volume rankings on multiple codes, the duration of enumeration supports an interpretation of an enduring referral and care pattern rather than a short‑term spike.

There are nuanced utilization patterns across anti‑VEGF agents and diagnostics: while J0178 is dominant, other drug codes such as J2778 and J9035 show more typical national standing (J2778 at the 74th percentile and J9035 at the 72nd percentile), and J2777 appears often in raw claim counts but is described as typical (25th percentile). This mixed pattern suggests the provider predominantly uses one agent at scale while also billing a spectrum of retinal therapeutics and diagnostics, which may reflect clinical choice, payer coverage, or patient‑level factors rather than uniform substitution across agents.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,320	$690	$2.3M
J2778	Injection, ranibizumab, 0.1 mg	1,420	$180	$256.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,300	$100	$220.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,260	$90	$203.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,100	$30	$147.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,450	$30	$100.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	750	$80	$60.9K
J7999	Compounded drug, not otherwise classified	590	$70	$43.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	290	$110	$32.2K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	300	$100	$30.4K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Sean Garrity — 4 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	50	780	$690	$734.8K
J2777	36	50	9,000	$30	$525.8K
J2778	9	30	550	$180	$198K
67028	8	60	1,240	$90	$119K
J7999	20	50	490	$70	$46.8K
92242	7	10	40	$200	$23.5K
J9035	7	20	210	$50	$22.5K
92014	61	650	140	$80	$21.5K
99214	37	10,410	120	$80	$20.6K
92235	5	40	120	$100	$14.3K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Sean Garrity, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rasw, PC	AZ	Retina Specialist (Ophthalmology) Physician	$0	$11.6M
Torsten Wiegand	MA	Retina Specialist (Ophthalmology) Physician	$7.6M	$0
Mark Walsh	AZ	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Cameron Javid	AZ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
April Harris	AZ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Adam Chin	MA	Ophthalmology Physician	$3.4M	$870
David Lally	MA	Ophthalmology Physician	$3.2M	$670
Andre Witkin	MA	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Ryan Wong	AZ	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Brad Baker	MA	Retina Specialist (Ophthalmology) Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Sean Garrity, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Easter Seals Blake Foundation	AZ	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$80.8M
Cobros Iii, LLC	AZ	Community/Behavioral Health Agency	$0	$61.4M
Easter Seals Blake Foundation	AZ	Community/Behavioral Health Agency	$0	$24.3M
Saguaro Senior Living, Inc.	AZ	Assisted Living Facility	$0	$22.5M
Arizona Total Care LLC	AZ	Multi-Specialty Clinic/Center	$0	$16.7M
Community Medical Services Arizona-private, LLC	AZ	Methadone Clinic	$164.3K	$14.2M
Solace Behavioral Health LLC	AZ	Community/Behavioral Health Agency	$0	$11.9M
Devereux Foundation	AZ	Mental Illness Community Based Residential Treatment Facility	$0	$8.7M
Caring Connections For Special Needs, LLC	AZ	Community/Behavioral Health Agency	$0	$7.5M
Andreas Gonzalez	AZ	Ophthalmology Physician	$2.4M	$0

Sean Garrity — Billing Profile & Reimbursement Data

Sign up for Sean Garrity — Billing Profile & Reimbursement Data policy alerts

Sean Garrity — Billing Profile & Reimbursement Data

Sign up for Sean Garrity — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References